Ensign Peak Advisors, Inc
Position in IDYA — IDEAYA Biosciences, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in IDYA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$29,971,473
-$3,874,734 QoQ
Shares Held
899,504
-8.1% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,156,213,147 across 116 Biotechnology names. IDYA ranks #10 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in IDYA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,971,473 | 899,504 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $33,846,207 | 979,063 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $20,493,592 | 753,164 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $15,593,329 | 741,833 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,366,808 | 327,644 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $14,500,376 | 564,217 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,382,267 | 611,814 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,983,198 | 483,714 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,429,675 | 488,370 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $17,435,587 | 490,039 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,814,892 | 363,784 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,485,699 | 233,434 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,268,803 | 92,411 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,679,107 | 92,411 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,494,551 | 100,171 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,307,977 | 94,781 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,060,599 | 94,781 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,184,596 | 92,411 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $940,963 | 36,915 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $774,845 | 36,915 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $867,502 | 36,915 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $516,810 | 36,915 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $463,652 | 36,915 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||